EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport

John Haynes, Arnav Joshi iD, Ross C Larue iD, Eric D Eisenmann iD, Rajgopal Govindarajan iD

Pharmaceutics · 13.12.2024 · 16 (12) · 1592

DOI: 10.3390/pharmaceutics16121592 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 13.12.2024. Verfasst von John Haynes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleoside reverse transcriptase inhibitors (NRTIs) are the backbone of highly active antiretroviral therapy (HAART)—the current standard of care for treating human immunodeficiency virus (HIV) infection. Despite their efficacy, NRTIs cause numerous treatment-limiting adverse effects, including a distinct peripheral neuropathy, called antiretroviral toxic neuropathy (ATN). ATN primarily affects the extremities with shock-like tingling pain, a pins-and-needles prickling sensation, and numbness. Despite its negative impact on patient quality of life, ATN remains poorly understood, which limits treatment options and potential interventions for people living with HIV (PLWH). Elucidating the underlying pathophysiology of NRTI-induced ATN will facilitate the development of effective treatment strategies and improved patient outcomes. In this article, we will comprehensively review ATN in the setting of NRTI treatment for HIV infection.

Schlagwörter

Stichwörter der Autor:innen

HIV-induced neuropathyNRTIantiretroviral drugsantiretroviral toxic neuropathyperipheral neuropathy

Autor:innen und Institutionen

  • Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
  • Translational Therapeutics, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA.

ORCID-Profile: Arnav Joshi, Ross C Larue, Eric D Eisenmann, Rajgopal Govindarajan

Förderung

  • NHLBI NIH HHS
  • NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Haynes, J., Joshi, A., Larue, R. C., Eisenmann, E. D., & Govindarajan, R. (2024). Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport. Pharmaceutics, 16(12), 1592. https://doi.org/10.3390/pharmaceutics16121592

Vancouver

Haynes J, Joshi A, Larue RC, Eisenmann ED, Govindarajan R. Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport. Pharmaceutics. 2024;16(12):1592. doi:10.3390/pharmaceutics16121592

BibTeX
@article{Haynes2024,
  author = {Haynes, John and Joshi, Arnav and Larue, Ross C and Eisenmann, Eric D and Govindarajan, Rajgopal},
  title = {Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {12},
  pages = {1592},
  doi = {10.3390/pharmaceutics16121592}
}
Kostenlos starten →